Title : Development and biological investigations of hypoxia-sensitive prodrugs of the tyrosine kinase inhibitor crizotinib.

Pub. Date : 2020 Jun

PMID : 32229347






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In order to overcome this drawback, the first hypoxia-activatable 2-nitroimidazole-based prodrugs of the clinically approved ALK and c-MET inhibitor crizotinib were developed. azomycin ALK receptor tyrosine kinase Homo sapiens